ID   TAF1_MESAU              Reviewed;        1865 AA.
AC   Q60544;
DT   20-FEB-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   10-FEB-2021, entry version 105.
DE   RecName: Full=Transcription initiation factor TFIID subunit 1;
DE            EC=2.3.1.48;
DE            EC=2.7.11.1;
DE   AltName: Full=Cell cycle gene 1 protein;
DE   AltName: Full=TBP-associated factor 250 kDa;
DE            Short=p250;
DE   AltName: Full=Transcription initiation factor TFIID 250 kDa subunit;
DE            Short=TAF(II)250;
DE            Short=TAFII-250;
DE            Short=TAFII250 {ECO:0000303|PubMed:8163200};
GN   Name=TAF1; Synonyms=CCG1;
OS   Mesocricetus auratus (Golden hamster).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea;
OC   Cricetidae; Cricetinae; Mesocricetus.
OX   NCBI_TaxID=10036;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RX   PubMed=8163200; DOI=10.1016/0378-1119(94)90583-5;
RA   Hayashida T., Sekiguchi T., Noguchi E., Sunamoto H., Ohba T., Nishimoto T.;
RT   "The CCG1/TAFII250 gene is mutated in thermosensitive G1 mutants of the
RT   BHK21 cell line derived from golden hamster.";
RL   Gene 141:267-270(1994).
CC   -!- FUNCTION: Largest component and core scaffold of the TFIID basal
CC       transcription factor complex. Contains novel N- and C-terminal Ser/Thr
CC       kinase domains which can autophosphorylate or transphosphorylate other
CC       transcription factors. Phosphorylates TP53 on 'Thr-55' which leads to
CC       MDM2-mediated degradation of TP53. Phosphorylates GTF2A1 and GTF2F1 on
CC       Ser residues. Possesses DNA-binding activity (By similarity). Essential
CC       for progression of the G1 phase of the cell cycle (PubMed:8163200).
CC       Exhibits histone acetyltransferase activity towards histones H3 and H4
CC       (By similarity). {ECO:0000250|UniProtKB:P21675,
CC       ECO:0000269|PubMed:8163200}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=acetyl-CoA + L-lysyl-[protein] = CoA + H(+) + N(6)-acetyl-L-
CC         lysyl-[protein]; Xref=Rhea:RHEA:45948, Rhea:RHEA-COMP:9752,
CC         Rhea:RHEA-COMP:10731, ChEBI:CHEBI:15378, ChEBI:CHEBI:29969,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57288, ChEBI:CHEBI:61930; EC=2.3.1.48;
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC   -!- ACTIVITY REGULATION: Autophosphorylates on Ser residues. Inhibited by
CC       retinoblastoma tumor suppressor protein, RB1. Binding to TAF1 or CIITA
CC       inhibits the histone acetyltransferase activity.
CC       {ECO:0000250|UniProtKB:P21675}.
CC   -!- SUBUNIT: TAF1 is the largest component of transcription factor TFIID
CC       that is composed of TBP and a variety of TBP-associated factors. TAF1,
CC       when part of the TFIID complex, interacts with C-terminus of TP53. Part
CC       of a TFIID-containing RNA polymerase II pre-initiation complex that is
CC       composed of TBP and at least GTF2A1, GTF2A2, GTF2E1, GTF2E2, GTF2F1,
CC       GTF2H2, GTF2H3, GTF2H4, GTF2H5, GTF2B, TCEA1, ERCC2, ERCC3, TAF1, TAF2,
CC       TAF3, TAF4, TAF5, TAF6, TAF7, TAF8, TAF9, TAF10, TAF11, TAF12 and
CC       TAF13. Interacts with TAF7; the interaction is direct. Component of
CC       some MLL1/MLL complex, at least composed of the core components
CC       KMT2A/MLL1, ASH2L, HCFC1/HCF1, WDR5 and RBBP5, as well as the
CC       facultative components BAP18, CHD8, E2F6, HSP70, INO80C, KANSL1, LAS1L,
CC       MAX, MCRS1, MGA, KAT8/MOF, PELP1, PHF20, PRP31, RING2, RUVB1/TIP49A,
CC       RUVB2/TIP49B, SENP3, TAF1, TAF4, TAF6, TAF7, TAF9 and TEX10. RB1
CC       interacts with the N-terminal domain of TAF1. Interacts with ASF1A and
CC       ASF1B. Interacts (via bromo domains) with acetylated lysine residues on
CC       the N-terminus of histone H1.4, H2A, H2B, H3 and H4 (in vitro).
CC       {ECO:0000250|UniProtKB:P21675}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P21675}.
CC   -!- DOMAIN: The Bromo domain mediates interaction with histones that have
CC       acetylated lysine residues at specific positions. The second domain
CC       also recognizes and binds histones that are butyrylated and
CC       crotonylated. {ECO:0000250|UniProtKB:P21675}.
CC   -!- PTM: Phosphorylated by casein kinase II in vitro.
CC       {ECO:0000250|UniProtKB:P21675}.
CC   -!- SIMILARITY: Belongs to the TAF1 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D26114; BAA05110.1; -; mRNA.
DR   PIR; I48155; I48155.
DR   RefSeq; NP_001268498.1; NM_001281569.1.
DR   SMR; Q60544; -.
DR   GeneID; 101838159; -.
DR   CTD; 6872; -.
DR   OrthoDB; 103411at2759; -.
DR   Proteomes; UP000189706; Genome assembly.
DR   GO; GO:0071339; C:MLL1 complex; ISS:UniProtKB.
DR   GO; GO:0005669; C:transcription factor TFIID complex; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0004402; F:histone acetyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB.
DR   GO; GO:0106311; F:protein threonine kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0016251; F:RNA polymerase II general transcription initiation factor activity; IGI:ParkinsonsUK-UCL.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IMP:BHF-UCL.
DR   GO; GO:0006367; P:transcription initiation from RNA polymerase II promoter; IGI:ParkinsonsUK-UCL.
DR   Gene3D; 1.10.1100.10; -; 1.
DR   Gene3D; 1.20.920.10; -; 2.
DR   InterPro; IPR001487; Bromodomain.
DR   InterPro; IPR036427; Bromodomain-like_sf.
DR   InterPro; IPR018359; Bromodomain_CS.
DR   InterPro; IPR040240; TAF1.
DR   InterPro; IPR011177; TAF1_animal.
DR   InterPro; IPR009067; TAF_II_230-bd.
DR   InterPro; IPR036741; TAFII-230_TBP-bd_sf.
DR   InterPro; IPR022591; TFIID_sub1_DUF3591.
DR   InterPro; IPR041670; Znf-CCHC_6.
DR   PANTHER; PTHR13900; PTHR13900; 1.
DR   Pfam; PF00439; Bromodomain; 2.
DR   Pfam; PF12157; DUF3591; 1.
DR   Pfam; PF09247; TBP-binding; 1.
DR   Pfam; PF15288; zf-CCHC_6; 1.
DR   PIRSF; PIRSF003047; TAF1_animal; 1.
DR   PRINTS; PR00503; BROMODOMAIN.
DR   SMART; SM00297; BROMO; 2.
DR   SUPFAM; SSF47055; SSF47055; 1.
DR   SUPFAM; SSF47370; SSF47370; 2.
DR   PROSITE; PS00633; BROMODOMAIN_1; 2.
DR   PROSITE; PS50014; BROMODOMAIN_2; 2.
PE   2: Evidence at transcript level;
KW   Acetylation; Acyltransferase; ATP-binding; Bromodomain; Cell cycle;
KW   DNA-binding; Isopeptide bond; Kinase; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Reference proteome; Repeat;
KW   Serine/threonine-protein kinase; Transcription; Transcription regulation;
KW   Transferase; Ubl conjugation.
FT   CHAIN           1..1865
FT                   /note="Transcription initiation factor TFIID subunit 1"
FT                   /id="PRO_0000278523"
FT   DOMAIN          1..409
FT                   /note="Protein kinase 1"
FT   DOMAIN          1392..1462
FT                   /note="Bromo 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00035"
FT   DOMAIN          1420..1865
FT                   /note="Protein kinase 2"
FT   DOMAIN          1515..1585
FT                   /note="Bromo 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00035"
FT   DNA_BIND        1190..1268
FT                   /note="HMG box"
FT                   /evidence="ECO:0000250"
FT   REGION          512..971
FT                   /note="Histone acetyltransferase (HAT)"
FT                   /evidence="ECO:0000250"
FT   REGION          1337..1624
FT                   /note="Interaction with ASF1A and ASF1B"
FT                   /evidence="ECO:0000250"
FT   MOTIF           1346..1353
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        152..160
FT                   /note="Poly-Pro"
FT   COMPBIAS        178..185
FT                   /note="Poly-Ser"
FT   COMPBIAS        293..297
FT                   /note="Poly-Pro"
FT   COMPBIAS        1822..1829
FT                   /note="Poly-Glu"
FT   MOD_RES         131
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P21675"
FT   MOD_RES         302
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P21675"
FT   MOD_RES         539
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80UV9"
FT   MOD_RES         1664
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80UV9"
FT   MOD_RES         1667
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80UV9"
FT   MOD_RES         1773
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80UV9"
FT   MOD_RES         1776
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80UV9"
FT   MOD_RES         1794
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80UV9"
FT   MOD_RES         1821
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P21675"
FT   CROSSLNK        544
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P21675"
FT   CROSSLNK        557
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P21675"
SQ   SEQUENCE   1865 AA;  211868 MW;  A81614946C0C0F24 CRC64;
     MLLPATGASR SAAIMSDTDS DEDSSGGGPF SLTGFLFGNI NGAGQLEGES VLDDECKKHL
     AGLGALGLGS LITELTANEE LAGTDGALVN DEGWIRSRED AVDYSDINEV AEDESRRYQQ
     TMGSLQPLCH SADYDEDDYD ADCEDIDCKL MPPPPPPPGP VKKEKDQDGL TGEKVDFSSS
     SDSESEMGPQ EAAQAESKDG KLTLPLAGIM QHDATKLLPS VTELFPEFRP GKVLRFLRLF
     GPGKNVPSVW RSARRKRKKK HREPIQEEQI QEEECSVELE VNQKSLWNYD YAPPPPPEQC
     LSDDEITMMA PVESKFSQST GDTDKVMDTK PRVAEWRYGP ARLWYDMLGV PEDGSGFDYG
     FKMRKTEHEP AIKCKMMTKL RKLEESNGID LLADENFLMV TQLHWEDDII WDGEDVKHKG
     TKPQRASLAG WLPSSMTRNA MAYNVQQGFA ATLDDDKPWY SIFPIDNEDL VYGRWEDNII
     WDAQAMPRIL EPPVLTLDPN DENLILEIPD EKEEATSNSP SKENKKESSL KKSRILLGKT
     GVIKEEPQQN MSQPEVKDPW NLSNDEYYYP KQQGLRGTFG GNIIQHSIPA VELRQPFFPT
     HMGPIKLRQF HRPPLKKYSF GALSQPGPHS VQPLLKHIKK KAKMREQERQ ASGGGEMFFM
     RTPQDLTGKD GDLILAEYSE ENGPLMMQVG MATKIKNYYK RKPGKDPGAP DCKYGETVYC
     HTSPFLGSLH PGQLLQAFEN NLFRAPIYLH KMPETDFLII RTRQGYYIRE LVDIFVVGQQ
     CPLFEVPGPN SKRANTHIRD FLQVFIYRLF WKSKDRPRRI RMEDIKKAFP SHSESSIRKR
     LKLCADFKRT GMDSNWWVLK SDFRLPTEEE IRAMVSPEQC CAYYSMIAAE QRLKDAGYGE
     KSFFAPEEEN EEDFQMKIDD EVRTAPWNTT RAFIAAMKGK CLLEVTGVAD PTGCGEGFSY
     VKIPNKPTQQ KDDKEPQPVK KTVTGTDADL RRLSLKNAKQ LLRKFGVPEE EIKKLSRWEV
     IDVVRTMSTE QARSGEGPMS KFARGSRFSV AEHQERYKEE CQRIFDLQNK VLSSTEVLST
     DTDSSSAEDS DFEEMGKNIE NMLQNKKTSS QLSREREEQE RKELQRMLLA AGSASAGNNH
     RDDDTASVTS LNSSATGRCL KIYRTFRDEE GKEYVRCETV RKPAVIDAYV RIRTTKDEEF
     IRKFALFDEQ HREEMRKERR RIQEQLRRLK RNQEKEKLKG PPEKKPKKMK ERPDLKLKCG
     ACGAIGHMRT NKFCPLYYQT NAPPSNPVAM TEEQEEELEK TVIHNDNEEL IKVEGTKIVL
     GKQLIESADE VRRKSLVLKF PKQQLPPKKK RRVGTTVHCD YLNRPHKSIH RRRTDPMVTL
     SSILESIIND MRDLPNTYPF HTPVNAKVVK DYYKIITRPM DLQTLRENVR KRLYPSREEF
     REHLELIVKN SATYNGPKHS LTQISQSMLD LCDEKLKEKE DKLARLEKAI NPLLDDDDQV
     AFSFILDNIV TQKMMAVPDS WPFHHPVNKK FVPDYYKVIV SPMDLETIRK NISKHKYQSR
     ESFLDDVNLI LANSVKYNGS ESQYTKTAQE IVNVCYQTLT EYDEHLTQLE KDICTAKEAA
     LEEAELESLD PMTPGPYTPQ PPDLYDNSTS LSVSRDASVY QDESNMSVLD IPSATSEKQL
     TQEGEDGDGD LADEEEGTVQ QPQASVLYED LLMSEGEDDE EDAGSDEEGD NPFSAIQLSE
     SGSDSDVGSG SIRPKQPRVL QENTRMGMEN EESMMSYEGD GGEVSRGLED SNISYGSYEE
     PDPKSNTQDT SFSSIGGYEV SEEEEDEEEQ RSGPSVLSQV HLSEDEEDSE DFHSIAGDSD
     MDSDE
//
